Stay updated on Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page.

Latest updates to the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check16 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check45 days agoChange DetectedAdded site revision label v3.4.2 and removed the lapse-in-government-funding notice (and the previous v3.4.1 revision).SummaryDifference0.4%

- Check52 days agoChange DetectedNew site-wide notice explains potential processing delays due to a government funding lapse and updates the revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check59 days agoChange DetectedThe page now displays a glossary and adds QC/FEAR Act metadata (Last Update Submitted that Met QC Criteria and No FEAR Act Data), with the revision updated to v3.4.0 and the prior QC label and older revision removed.SummaryDifference0.2%

- Check73 days agoChange DetectedThe update shows a revision from v3.3.3 to v3.3.4 with no visible edits to the study details or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page.